(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.87%) $83.12
(-1.16%) $1.619
(-0.49%) $2 335.80
(0.67%) $27.44
(0.44%) $926.20
(-0.19%) $0.933
(-0.16%) $11.01
(-0.25%) $0.798
(0.00%) $92.17
Live Chart Being Loaded With Signals
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, Netherlands, Ireland, rest of Europe, the United States, and internationally...
Stats | |
---|---|
Dagens volum | 163 800 |
Gjennomsnittsvolum | 93 776.00 |
Markedsverdi | 4.17M |
EPS | £0 ( 2023-12-05 ) |
Neste inntjeningsdato | ( £0 ) 2024-05-20 |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -4.31 |
ATR14 | £0 (0.00%) |
IXICO PLC Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
IXICO PLC Økonomi
Annual | 2023 |
Omsetning: | £6.67M |
Bruttogevinst: | £2.85M (42.70 %) |
EPS: | £-0.0244 |
FY | 2023 |
Omsetning: | £6.67M |
Bruttogevinst: | £2.85M (42.70 %) |
EPS: | £-0.0244 |
FY | 2022 |
Omsetning: | £8.64M |
Bruttogevinst: | £4.77M (55.18 %) |
EPS: | £0.0214 |
FY | 2021 |
Omsetning: | £9.19M |
Bruttogevinst: | £6.02M (65.55 %) |
EPS: | £0.0335 |
Financial Reports:
No articles found.
IXICO PLC
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, Netherlands, Ireland, rest of Europe, the United States, and internationally. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer. Its focused therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis and other demyelinating diseases, Progressive Supranuclear Palsy, and other rare neurological diseases. The company also engages in the data collection, optimization, and analytics of rare neurological disorders; offers drug development analytics, imaging operation services, and post marketing surveillance services, as well as consultancy services; and provides end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.